These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 23970469)

  • 1. Serum eyedrops antagonize the anti(lymph)angiogenic effects of bevacizumab in vitro and in vivo.
    Hos D; Koch KR; Bucher F; Bock F; Cursiefen C; Heindl LM
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6133-42. PubMed ID: 23970469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis.
    Bock F; Onderka J; Dietrich T; Bachmann B; Kruse FE; Paschke M; Zahn G; Cursiefen C
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2545-52. PubMed ID: 17525183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical Ranibizumab inhibits inflammatory corneal hem- and lymphangiogenesis.
    Bucher F; Parthasarathy A; Bergua A; Onderka J; Regenfuss B; Cursiefen C; Bock F
    Acta Ophthalmol; 2014 Mar; 92(2):143-8. PubMed ID: 22994268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Lymphangiogenesis and Hemangiogenesis in Corneal Inflammation by Subconjunctival Prox1 siRNA Injection in Rats.
    Rho CR; Choi JS; Seo M; Lee SK; Joo CK
    Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5871-9. PubMed ID: 26348636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation.
    Hos D; Bock F; Dietrich T; Onderka J; Kruse FE; Thierauch KH; Cursiefen C
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1836-42. PubMed ID: 18436817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn.
    Yoeruek E; Ziemssen F; Henke-Fahle S; Tatar O; Tura A; Grisanti S; Bartz-Schmidt KU; Szurman P;
    Acta Ophthalmol; 2008 May; 86(3):322-8. PubMed ID: 17995975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety profile of topical VEGF neutralization at the cornea.
    Bock F; Onderka J; Rummelt C; Dietrich T; Bachmann B; Kruse FE; Schlötzer-Schrehardt U; Cursiefen C
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2095-102. PubMed ID: 19151400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Novel Endogenous Anti(lymph)angiogenic Factors in the Aqueous Humor.
    Bock F; Onderka J; Braun G; Schneider AC; Hos D; Bi Y; Bachmann BO; Cursiefen C
    Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6554-6560. PubMed ID: 27918829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corneal Collagen Cross-Linking With Riboflavin and UVA Regulates Hemangiogenesis and Lymphangiogenesis in Rats.
    Zhu Y; Li L; Reinach PS; Li Y; Ge C; Qu J; Chen W
    Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3702-3712. PubMed ID: 30029257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of lymphangiogenesis in vitro and in vivo by the multikinase inhibitor nintedanib.
    Lin T; Gong L
    Drug Des Devel Ther; 2017; 11():1147-1158. PubMed ID: 28435226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sunitinib inhibits inflammatory corneal lymphangiogenesis.
    Detry B; Blacher S; Erpicum C; Paupert J; Maertens L; Maillard C; Munaut C; Sounni NE; Lambert V; Foidart JM; Rakic JM; Cataldo D; Noël A
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3082-93. PubMed ID: 23580490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of insulin receptor substrate-1 inhibits corneal lymphangiogenesis.
    Hos D; Regenfuss B; Bock F; Onderka J; Cursiefen C
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5778-85. PubMed ID: 21666240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxycycline enhances the inhibitory effects of bevacizumab on corneal neovascularization and prevents its side effects.
    Su W; Li Z; Li Y; Lin M; Yao L; Liu Y; He Z; Wu C; Liang D
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9108-15. PubMed ID: 22039247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoids suppress corneal lymphangiogenesis.
    Steele MM; Kelley PM; Schieler AM; Tempero RM
    Cornea; 2011 Dec; 30(12):1442-7. PubMed ID: 21955630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation.
    Bachmann BO; Bock F; Wiegand SJ; Maruyama K; Dana MR; Kruse FE; Luetjen-Drecoll E; Cursiefen C
    Arch Ophthalmol; 2008 Jan; 126(1):71-7. PubMed ID: 18195221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.
    Cursiefen C; Schlötzer-Schrehardt U; Küchle M; Sorokin L; Breiteneder-Geleff S; Alitalo K; Jackson D
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2127-35. PubMed ID: 12091407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin).
    Kim TI; Kim SW; Kim S; Kim T; Kim EK
    Cornea; 2008 Apr; 27(3):349-52. PubMed ID: 18362666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early effects of dexamethasone and anti-VEGF therapy in an inflammatory corneal neovascularization model.
    Mirabelli P; Peebo BB; Xeroudaki M; Koulikovska M; Lagali N
    Exp Eye Res; 2014 Aug; 125():118-27. PubMed ID: 24933712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenesis Effect of Albendazole on the Cornea.
    Cho YK; Shin EY; Uehara H; Ambati B
    J Ocul Pharmacol Ther; 2019 May; 35(4):254-261. PubMed ID: 31033390
    [No Abstract]   [Full Text] [Related]  

  • 20. Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis.
    Chen WL; Lin CT; Lin NT; Tu IH; Li JW; Chow LP; Liu KR; Hu FR
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1659-65. PubMed ID: 18997093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.